Trial Phase
Trial Status
Paid Participation
Clear All
15 Graves' disease Trials near Chicago, IL
Power is an online platform that helps thousands of Graves' Disease patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Satralizumab for Thyroid Eye Disease
Chicago, IllinoisVRDN-001 for Thyroid Eye Disease
Chicago, IllinoisBatoclimab for Graves' Eye Disease
Chicago, IllinoisLinsitinib for Thyroid Eye Disease
Chicago, IllinoisNew Treatment for Graves' Eye Disease
Oak Lawn, IllinoisKey Eligibility Criteria
VRDN-003 for Graves' Eye Disease
Orland Park, IllinoisKey Eligibility Criteria
VRDN-003 for Graves' Eye Disease
Orland Park, IllinoisKey Eligibility Criteria
VRDN-001 for Thyroid Eye Disease
Orland Park, IllinoisKey Eligibility Criteria
Teprotumumab for Graves' Eye Disease
Orland Park, IllinoisKey Eligibility Criteria
Satralizumab for Thyroid Eye Disease
Saint Joseph, MichiganBatoclimab for Graves' Eye Disease
Milwaukee, WisconsinKey Eligibility Criteria
Batoclimab for Thyroid Eye Disease
Milwaukee, WisconsinKey Eligibility Criteria
Teprotumumab for Thyroid Eye Disease
Milwaukee, WisconsinDexamethasone for Autoimmune Thyroid Disease
Indianapolis, IndianaKey Eligibility Criteria
CABA-201 for Myasthenia Gravis
Chicago, IllinoisKey Eligibility Criteria
Frequently Asked Questions
How much do Graves' disease clinical trials in Chicago, IL pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Graves' disease clinical trials in Chicago, IL work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Graves' disease trials in Chicago, IL 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Chicago, IL for Graves' disease is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Chicago, IL several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Graves' disease medical study in Chicago, IL ?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Graves' disease clinical trials in Chicago, IL ?
Most recently, we added CABA-201 for Myasthenia Gravis, VRDN-003 for Graves' Eye Disease and VRDN-003 for Graves' Eye Disease to the Power online platform.